Applicant, as named in the Orange Book
Upsher Smith Labs
Next listed expiry: Qudexy Xr on 19 Mar 2033. 1 products with live protection, 1 without.
Products with listed protection
| Drug | Earliest generic entry |
|---|---|
| Qudexy Xr NDA 205122 · 5 strengths topiramate | 19 Mar 2033 patent |
Recent events
- Qudexy Xr · Generic approved · ANDA 220041, Riconpharma LlcApproved 26 May 2026Detected 25 Oct 2026
- Qudexy Xr · Generic approved · ANDA 220943, Biocon PharmaApproved 22 Jul 2026Detected 25 Oct 2026
- Qudexy Xr · Generic approved · ANDA 217443, Ascent Pharms IncApproved 12 Jan 2026Detected 25 Oct 2026
- Qudexy Xr · Generic approved · ANDA 219183, Micro LabsApproved 4 Sep 2026Detected 25 Oct 2026
Products without listed protection (1)
| Drug | Earliest generic entry |
|---|---|
| Klor-Con NDA 019123 · 2 strengths potassium chloride | open now no listed protection |